Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Healthcare Services Industry Analysis

UpdatedAug 30, 2026
DataAggregated Company Financials
Companies161
  • 7D-0.2%
  • 3M8.0%
  • 1Y21.9%
  • YTD15.9%

Over the last 7 days, the Healthcare Services industry has remained flat, although notably McKesson gained 4.0%. As for the the longer term, the industry is up 22% over the past 12 months. As for the next few years, earnings are expected to grow by 17% per annum.

Industry Valuation and Performance

Has the U.S. Healthcare Services Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 30 Aug 2026US$1.0tUS$2.3tUS$36.7b25x28.4x0.5x
Tue, 28 Jul 2026US$1.1tUS$2.2tUS$32.3b26.1x33.7x0.5x
Thu, 25 Jun 2026US$1.0tUS$2.2tUS$30.0b23.6x34.7x0.5x
Sat, 23 May 2026US$977.8bUS$2.2tUS$30.0b24.6x32.6x0.4x
Mon, 20 Apr 2026US$876.7bUS$2.2tUS$28.0b23.5x31.3x0.4x
Wed, 18 Mar 2026US$822.2bUS$2.2tUS$27.7b21.9x29.7x0.4x
Fri, 13 Feb 2026US$851.1bUS$2.2tUS$28.8b23.3x29.5x0.4x
Sun, 11 Jan 2026US$925.0bUS$2.1tUS$34.8b22.9x26.5x0.4x
Tue, 09 Dec 2025US$882.7bUS$2.1tUS$34.9b22.1x25.3x0.4x
Thu, 06 Nov 2025US$886.7bUS$2.1tUS$35.3b21.5x25.2x0.4x
Sat, 04 Oct 2025US$915.7bUS$2.1tUS$49.3b21.4x18.6x0.4x
Mon, 01 Sep 2025US$859.7bUS$2.1tUS$49.3b21.5x17.4x0.4x
Wed, 30 Jul 2025US$785.3bUS$2.1tUS$50.1b20.1x15.7x0.4x
Fri, 27 Jun 2025US$867.6bUS$2.1tUS$52.7b22x16.5x0.4x
Sun, 25 May 2025US$853.4bUS$2.1tUS$52.5b19.2x16.2x0.4x
Tue, 22 Apr 2025US$956.9bUS$1.7tUS$49.4b22.2x19.4x0.6x
Thu, 20 Mar 2025US$1.0tUS$1.7tUS$41.5b23.8x24.4x0.6x
Sat, 15 Feb 2025US$1.0tUS$1.7tUS$41.2b23.3x25.3x0.6x
Mon, 13 Jan 2025US$1.0tUS$2.0tUS$42.2b21.6x24.5x0.5x
Wed, 11 Dec 2024US$1.1tUS$2.0tUS$41.4b23.6x26.7x0.6x
Fri, 08 Nov 2024US$1.2tUS$2.0tUS$41.4b25.5x28.3x0.6x
Sun, 06 Oct 2024US$1.2tUS$1.9tUS$43.3b24.5x27.4x0.6x
Tue, 03 Sep 2024US$1.2tUS$1.9tUS$43.3b26.6x28.3x0.6x
Thu, 01 Aug 2024US$1.2tUS$1.9tUS$43.0b27.4x27.9x0.6x
Sat, 29 Jun 2024US$1.1tUS$1.9tUS$43.4b24.6x24.9x0.6x
Mon, 27 May 2024US$1.1tUS$1.9tUS$43.3b26.5x25.2x0.6x
Wed, 24 Apr 2024US$1.1tUS$1.9tUS$43.0b25.9x25.7x0.6x
Fri, 22 Mar 2024US$1.1tUS$1.8tUS$49.6b24.4x22.8x0.6x
Sun, 18 Feb 2024US$1.1tUS$1.8tUS$49.9b24x23x0.6x
Tue, 16 Jan 2024US$1.2tUS$1.8tUS$50.8b24x22.7x0.6x
Thu, 14 Dec 2023US$1.2tUS$1.8tUS$51.2b23.3x22.9x0.7x
Sat, 11 Nov 2023US$1.1tUS$1.8tUS$51.2b21.7x22.4x0.6x
Mon, 09 Oct 2023US$1.1tUS$1.8tUS$46.9b22.4x24x0.6x
Wed, 06 Sep 2023US$1.1tUS$1.8tUS$46.7b21.7x23.1x0.6x
Price to Earnings Ratio

23.1x


Total Market Cap: US$1.1tTotal Earnings: US$46.7bTotal Revenue: US$1.8tTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Healthcare Services Industry Price to Earnings3Y Average 24.8x202420252026
Current Industry PE
  • Investors are optimistic on the American Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 28.6x which is higher than its 3-year average PE of 24.8x.
  • The industry is trading close to its 3-year average PS ratio of 0.52x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 7.7% per year over the last three years.
  • Meanwhile revenues for these companies have grown 8.8% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the U.S. Healthcare industry?

US Market0.28%
Healthcare-2.15%
Healthcare Services-0.16%
Healthcare Distributors1.27%
Managed Healthcare0.24%
Healthcare Services-0.43%
Healthcare Facilities-2.95%
Industry PE
  • Investors are most optimistic about the Managed Healthcare industry which is trading above its 3-year average PE ratio of 24.8x.
    • Analysts are expecting annual earnings growth of 19.2%, which is higher than its past year's earnings decline of 13.1% per year.
  • Investors are most pessimistic about the Healthcare Facilities industry, which is trading close to its 3-year average of 18.5x.
Forecasted Growth
  • Analysts are most optimistic on the Managed Healthcare industry, expecting annual earnings growth of 19% over the next 5 years.
  • This is better than its past earnings decline of 13% per year.
  • In contrast, the Healthcare Distributors industry is expected to see its earnings grow by 7.7% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
MCK McKessonUS$893.394.0%
+US$4.0b		30.1%PE22.7x
UNH UnitedHealth GroupUS$392.950.7%
+US$2.5b		26.8%PE25x
CAH Cardinal HealthUS$234.552.2%
+US$1.2b		57.6%PE31.8x
HUM HumanaUS$385.541.8%
+US$799.7m		27.0%PE36.2x
COR CencoraUS$322.031.3%
+US$761.4m		10.4%PE23.4x

Latest News

HQY
US$96.37
HealthEquity
7D
-8.6%
1Y
7.9%
HIMS
US$28.84
Hims & Hers Health
7D
-14.6%
1Y
-31.9%
HUM
US$385.54
Humana
7D
1.8%
1Y
27.0%
ENSG
US$172.98
Ensign Group
7D
-3.6%
1Y
0.7%
MCK
US$893.39
McKesson
7D
4.0%
1Y
30.1%
THC
US$266.80
Tenet Healthcare
7D
-5.0%
1Y
44.7%
CI
US$278.88
Cigna Group
7D
0.5%
1Y
-7.3%
UHS
US$171.66
Universal Health Services
7D
-3.2%
1Y
-5.5%
Seeking Alpha • Aug 27

The Pricing Power Prescription: Unlocking Universal Health Services' Hidden Fair Value

Summary Universal Health Services is deeply undervalued at 7.4x 2026E NTM earnings despite robust free cash flow and pricing power. Structural tailwinds in behavioral health, high ROIIC (15.5%), and disciplined share buybacks drive 12.1% FCFE-per-share CAGR through 2030E. Scenario analysis shows downside protection at current prices, with a base case fair value of $280.99 and a recommended accumulation limit of $217. Key catalysts include labor cost reductions, aggressive buybacks, and resolution of Medicaid payment uncertainties, while risks are mitigated by pricing power and geographic diversification. Read the full article on Seeking Alpha
NEO
US$18.05
NeoGenomics
7D
6.3%
1Y
105.6%
CAH
US$234.55
Cardinal Health
7D
2.2%
1Y
57.6%
Narrative Update • Aug 26

CAH: Higher-Margin Services And Generics Will Support EPS Delivery Into FY27

The analyst fair value estimate for Cardinal Health has increased from $264.73 to $270.94 as analysts factor in higher expected margins from integrated services, contributions from Sonexus and nuclear medicine, and updated Street price targets that now generally fall in the mid to high $200s. Analyst Commentary Recent Street research on Cardinal Health points to a cluster of higher price targets and generally constructive views on execution in pharma distribution, integrated services, and earnings visibility into fiscal 2027.
COR
US$322.03
Cencora
7D
1.3%
1Y
10.4%
GH
US$161.50
Guardant Health
7D
-5.4%
1Y
139.5%
DVA
US$180.68
DaVita
7D
3.9%
1Y
31.2%
Narrative Update • Aug 26

DVA: Volume Recovery And Care Expansion Will Shape Future Stock Economics

Analysts nudged their blended price target for DaVita higher to about $218 from about $209. This reflects adjustments to assumptions around revenue growth, profit margins, and future P/E after a mix of recent target increases and one reduction across the Street.
UNH
US$392.95
UnitedHealth Group
7D
0.7%
1Y
26.8%
Narrative Update • Aug 25

UNH: Medicare Advantage Recovery Will Support Durable Earnings Resilience

Analysts have lifted the UnitedHealth Group fair value estimate from $492.00 to $529.00. This reflects updated models that factor in recent Q2 earnings strength, Medicare recovery and improved margin expectations at UnitedHealthcare and Optum Health.
HCA
US$417.82
HCA Healthcare
7D
-2.6%
1Y
3.4%
Narrative Update • Aug 25

HCA: Payer Mix Deterioration Will Pressure Earnings And Justify A Lower Multiple

Analysts have reduced the fair value estimate for HCA Healthcare to $380 from $396, citing lower modeled revenue growth and profit margins, as well as a slightly higher discount rate. Some Street price targets remain higher, reflecting expectations for resilient hospital volumes and cash flow.
ELV
US$394.43
Elevance Health
7D
-1.5%
1Y
23.8%